Crohn’s and Colitis Canada Awards $2.8M in IBD Research Projects

Crohn’s and Colitis Canada Awards $2.8M in IBD Research Projects
4
(1)

In hopes of finding new treatments and developing programs to aid Canadians with inflammatory bowel disease (IBD), Crohn’s and Colitis Canada is granting $2.8 million to 11 teams of scientists.

The annual donor-funded awards are granted to those projects with the most potential to produce new therapies for the 270,000 Canadians who have Crohn’s disease or ulcerative colitis — the main forms of IBD, the organization said. By 2030, the number of patients in Canada is projected to exceed 400,000.

“Canada has among the highest rates of Crohn’s disease and ulcerative colitis in the world, and we are determined to drive discovery, the only way to prevent and cure these chronic and debilitating diseases,” Mina Mawani, president and CEO of Crohn’s and Colitis Canada, said in a press release.

Each year, IBD costs Canada $2.6 billion. The disease also takes a toll on the quality of life of patients, who are twice as likely as the general population to develop depression and anxiety.

For researchers, disparate challenges are growing in urgency: while older adults are experiencing the fastest climb in disease rates, the number of cases in children have increased by more than 50% within the last decade.

The high incidence rates led to Crohn’s and Colitis Canada’s Grants-in-Aid funding program, which awards scientists and their teams $125,000 annually for three years. Recipients of Innovation Awards get $50,000 for one year. The grants-in-aid program helps advance health policy and IBD prevention efforts, plus searches for treatments and cures. Innovations grants support new or innovative approaches to IBD research.

“Our competition is open to all types of research, and a collective review team built with scientific experts, nurses and people living with IBD ensures that we direct funding to the most promising projects for real impact,” said Kate Lee, the non-profit’s vice president of research and patient programs. “These eleven projects bring diverse strategies to the table for driving new therapies and diagnostics.”

This year’s Grants-in-Aid of Research recipients are awarded to:

— Laura Sly, University of British Columbia, to study a new therapy’s ability to block Crohn’s inflammation in cases involving low levels of the SHIP1 protein. Some studies have linked that protein to disease progression.

— Carolina Tropini, University of British Columbia, who will develop algorithms to try to predict the state of IBD. Tropini also will assess the effectiveness of new medicines on healthy-gut restoration.

— Bruce Vallance, Children’s and Women’s Health Center of British Columbus, who plans to learn how harmful intestinal bacteria cause ulcerative colitis. He also will identify new therapy targets.

— Stephen Vanner, Queen’s University, to investigate targeted opioid delivery to gut neurons. The hope is to find new ways to treat IBD stomach pain.

— Elena Verdu, McMaster University, who plans to target inflammation-causing bacterial enzymes to produce new microbiome-based ulcerative colitis treatments.

— Pierre-Yves von der Weid, University of Calgary, to study whether a dysfunctional lymphatic system perpetuates gut inflammation in Crohn’s.

— Robert Young, Simon Fraser University, who hopes to develop an IBD medication that will safely repair and protect the gut lining.

The 2019 Innovations in IBD Research awards were given to:

— Jean-Francois Beaulieu, Universite de Sherbrooke, who hopes to use mass spectrometry to identify new IBD biomarkers.

— Harry Brumer, University of British Columbia, to study a new version of a peptide for possible IBD targeted treatment.

— Jean Sévigny, Universite Laval, who will seek to create a novel IBD therapy with the NTPDase8 enzyme.

— Sara Ahola Kohut, Hospital for Sick Children, for studying the impact on IBD parents of a new online workshop, “Acceptance and Commitment Training.”

Crohn’s and Colitis Canada is focused on finding IBD cures and improving the lives of patients and caregivers.

Mary M. Chapman began her professional career at United Press International, running both print and broadcast desks. She then became a Michigan correspondent for what is now Bloomberg BNA, where she mainly covered the automotive industry plus legal, tax and regulatory issues. A member of the Automotive Press Association and one of a relatively small number of women on the car beat, Chapman has discussed the automotive industry multiple times of National Public Radio, and in 2014 was selected as an honorary judge at the prestigious Cobble Beach Concours d’Elegance. She has written for numerous national outlets including Time, People, Al-Jazeera America, Fortune, Daily Beast, MSN.com, Newsweek, The Detroit News and Detroit Free Press. The winner of the Society of Professional Journalists award for outstanding reporting, Chapman has had dozens of articles in The New York Times, including two on the coveted front page. She has completed a manuscript about centenarian car enthusiast Margaret Dunning, titled “Belle of the Concours.”
Total Posts: 455
Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.
×
Mary M. Chapman began her professional career at United Press International, running both print and broadcast desks. She then became a Michigan correspondent for what is now Bloomberg BNA, where she mainly covered the automotive industry plus legal, tax and regulatory issues. A member of the Automotive Press Association and one of a relatively small number of women on the car beat, Chapman has discussed the automotive industry multiple times of National Public Radio, and in 2014 was selected as an honorary judge at the prestigious Cobble Beach Concours d’Elegance. She has written for numerous national outlets including Time, People, Al-Jazeera America, Fortune, Daily Beast, MSN.com, Newsweek, The Detroit News and Detroit Free Press. The winner of the Society of Professional Journalists award for outstanding reporting, Chapman has had dozens of articles in The New York Times, including two on the coveted front page. She has completed a manuscript about centenarian car enthusiast Margaret Dunning, titled “Belle of the Concours.”
Latest Posts
  • takeda research collaboration
  • CT-SCOUT app studied
  • gut microbes
  • Genedata

How useful was this post?

Click on a star to rate it!

Average rating 4 / 5. Vote count: 1

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?